Skip to content

Clinical trials

Phase 2 Respiratory Syncytial Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Phase 2 Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20101
20111
20121
20131
20143
20153
20166
20172
20185
20194
20205
20213
20222
20234
20244
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated7
Recruiting5
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline9
Enanta Pharmaceuticals, Inc5
Gilead Sciences5
Alnylam Pharmaceuticals3
Janssen Research & Development, LLC3
Shanghai Ark Biopharmaceutical Co., Ltd.3
Alios Biopharma Inc.2
Bavarian Nordic2
Janssen Sciences Ireland UC2
MedImmune LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections56
Virus Diseases3
Respiratory Tract Infections2
Autoimmune Diseases1
Infections1
Neoplasms1
Pneumonia1
Premature Birth1
Respiration Disorders1

Trials

Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.